29 Aug Madison biotech Isomark appoints Daniel Stewart as CEO
Madison, Wis. – Daniel J. Stewart, an executive who has worked with the National Institutes of Health and as a public policy analyst, has been named president and chief executive officer for Isomark, LLC, an early-stage biotechnology company located in Madison’s University Research Park.
The appointment was announced by Dr. Mark Cook, Isomark’s board chairman and co-founder.
Prior to joining Isomark, Stewart had nearly two decades of executive-level business leadership experience, including work with the National Institutes of Health, and as a public policy analyst on business, economic, and healthcare issues.
The company also appointed Curtis M. Haugen, former CEO of S’curo Group in Middleton, as its chief marketing officer.
Isomark was founded in 2005 by seven scientists from the University of Wisconsin-Madison. The company has developed a non-invasive platform technology, which is applied to medical diagnostic equipment, for the early detection of disease or disease states.
The technology uses mass spectroscopy to identify specific biomarkers in human breath, accelerate the detection of disease or infection, and facilitate earlier medical intervention.
• Jim Leonhart: Happy days are here for Wisconsin biotechnology
• Research park to add “accelerator” suites
• aOva Technologies raises $3 million